To bring personalized cancer care based on the most advanced genomic diagnostics to every corner of the world and have the benefits accessible to all. To continuously expand our knowledge and capabilities in order to provide the most efficient and effective products and services for cancer prevention, detection, treatment and monitoring.
Constant in-house research is carried out on our end-to-end specialized “From Sample to Report” platform. Our expert research teams cover all the disciplines required to develop superior genomic tests.
Our in-house research is combined with the knowledge gained through our partnerships to develop new specific cancer tests, whilst consistently updating and improving the existing product portfolio.
Our comprehensive in-house expertize permits the results of our R&D on new or existing products to be commercialized within a very short time-to-market.
Head of Product
Head of Molecular R&D
Head of molecular Analysis
Head of Business Development
Head of Bioinformatics
Executive Vice President